• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsOdonate
    Picture of Odonate logo

    ODTC — Odonate Share News

    $150,000.000.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro Cap
    • Market Cap
    • Enterprise Value
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ODTC Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ODTC Dividends
    • U.S. RESEARCH ROUNDUP-Accenture, Delphi Technologies, McDonald's

      28/06/2019 09:11
    • U.S. STOCKS ON THE MOVE-Gold miners, chip stocks, General Mills

      26/06/2019 14:14
    • Brief: Odonate Therapeutics Says Offering Of Common Shares Priced At $26/Share

      26/06/2019 14:14
    • Odonate Therapeutics: Falls after pricing upsized stock deal

      26/06/2019 13:50
    • Brief: Odonate Therapeutics Announces Public Offering Of Shares Of Common Stock

      25/06/2019 21:14
    • Brief: Odonate Therapeutics Announces Financial Results For The Three Months Ended March 31, 2019

      25/04/2019 14:20
    • Brief: Odonate Therapeutics Announces Initiation Of Contessa 2 Study Of Tesetaxel

      04/03/2019 21:33
    • Brief: Odonate Therapeutics Q4 Loss Per Share $1.17

      22/02/2019 13:28
    • Brief: Odonate TherapeuticsFiles For Stock Offering Of Upto $150 Mln

      22/02/2019 12:52
    • Brief: Odonate Therapeutics - Promoted John Lemkey To COO

      26/11/2018 22:12
    • Brief: Odonate Therapeutics Q3 Loss Per Share $0.98

      23/10/2018 13:08
    • Brief: Odonate Therapeutics Qtrly Loss Per Share $0.79

      30/07/2018 21:27
    • Brief: Odonate Therapeutics Qtrly Loss Per Share $0.69

      03/05/2018 21:47
    • Brief: Odonate Therapeutics Q4 Loss Per Share $0.81

      14/02/2018 13:15
    • Brief: Odonate Therapeutics Announces Initiation Of CONTESSA, A Phase 3 Study Of Tesetaxel In Patients With Locally Advanced Or Metastatic Breast Cancer

      28/12/2017 14:00
    • Brief: Odonate Holdings Llc Reports A 11.5 Pct Stake In Odonate Therapeutics As Of Dec 6

      18/12/2017 21:56
    • Brief: Boxer Capital LLC Reports 10.0 Pct Stake In Odonate Therapeutics As Of Dec 6

      08/12/2017 22:15
    • Brief: Odonate Therapeutics Announces Pricing Of Initial Public Offering

      07/12/2017 01:55
    Previous123Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.